MEGARON ATHENS INTERNATIONAL CONFERENCE CENTRE, 31/05 - 03/06/2018 ΙΑSIS PHARMA, also contributing to the field of Gynecology, participated successfully in the 14th Panhellenic Conference on Obstetrics and Gynecology, which took place on May 31st- June 3rd, at Megaron Athens International Conference Centre. The particular meeting is the leading event of the Hellenic Society of Obstetrics [...]
Royal Olympic Hotel, Athens, 30- 31/03/2018 IASIS PHARMA participated with great success as a Main Sponsor in the 23rd Greek Conference for Helicobacter pylori and Other Infections of the Digestive Tract. The conference was co-organized by the Greek Society for the Study of H. pylori (E.E.M.E.P.) and the Hellenic Society for Infectious Diseases. ΙΑSIS PHARMA [...]
MAKEDONIA PALACE HOTEL, THESSALONIKI, 30-31/03/2018 IΑSIS PHARMA showed its strong dedication in the field of Dermatology, by participating in the Annual Spring Day Conference of the Hellenic Society of Dermatology and Venereology, organized under the theme: “Therapeutic dilemmas in Dermatology – Venereology”. The event was held at Makedonia Palace Hotel, Thessaloniki, March 30th -31st [...]
Chios Mastic Museum, isle of Chios, Greece, 27/1/2018 Chios Mastiha Research & Development Center was presented on January 27th 2018, at an event which took place in the isle of Chios, at Chios Mastic Museum. Being constructed with pharmaceutical industry specifications, the R&D Center is founded by worthy partners: - IASIS PHARMA and its affiliated [...]
Kifissia, Athens, 19/1/2018 _ The whole IASIS PHARMA family was present at New Year's dinner and celebrative cake ceremony, for 2018. The event was held in Kifissia and all colleagues had the opportunity to meet and exchange wishes for the new year in a beautiful night. The management team set the milestones for 2018; health, [...]
IASIS PHARMA announces the launch of MAG-IASIS®, the first uniquely effective combination indicated for magnesium deficiency in the form of effervescent tablets. Each effervescent tablet of MAG-IASIS® contains: 1193.57 mg magnesium citrate & 667.56 mg magnesium aspartate equivalent to 243 mg Magnesium. MAG-IASIS® main indications are: ● magnesium deficiency, under the condition that it cannot [...]
IASIS PHARMA has launched a new pharmaceutical product under the brand name of ZALEPIN® RAPID, enriching its CNS product portfolio. ZALEPIN® RAPID contains Olanzapine as its active ingredient and belongs to the class of atypical antipsychotic agents, the newer generation of antipsychotics. ZALEPIN® RAPID is available in the form of orodispersible tablets (ODT), offering the [...]
DIVANI CARAVEL HOTEL, ATHENS, 2-3/12/2017 ΙΑSIS PHARMA successfully participated in the 15th 2-Day Educational Workshop on Functional Diseases of the Peptic System, which took place at Divani - Caravel Hotel in Athens, December 2 - 3, 2017. The event was organized by the Professional Association of Greek Gastroenterologists (EPEGE). The workshop focused on the diseases [...]
TITANIA HOTEL, ATHENS, 24-25/11/2017 IASIS PHARMA actively contributed as a sponsor to the 2nd Training Seminar, under the title: "HEART, DIABETES AND MUSCULOSCELETAL SYSTEM - ALL THE LATEST DEVELOPMENTS". The event took place at Titania Hotel Athens, November 24-25th 2017 and was organized by the Freelance Doctors Union of ATTICA region.
MACEDONIA PALACE HOTEL, THESSALONIKI, 2-5/11/2017 From November 3rd to 6th 2017, the Hellenic Society of Dermatology and Venereology (EDAE) held the 13th Panhellenic Conference of Dermatology & Venereology, at Makedonia Palace hotel, in Thessaloniki, capital of Northern Greece, Macedonia. IASIS PHARMA was present, attending the conference with success. The conference aimed to update dermatologists on [...]
